Patients taking medications that can cause hypoglycaemia (such as when GLP-1 therapy is combined with insulin or sulfonylureas) should follow DVLA 'Assessing fitness to drive' guidance, including appropriate glucose monitoring before and during driving
proportion of participants who achieved body weight reduction thresholds and fat mass reduction thresholds at weeks 48 and 72
Diabetes Care 28 , 19361940 (2005)
Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: Observational and Mendelian randomization analyses with 430,000 women
Mann JF, Green D, Jamerson K, Ruilope LM, Kuranoff SJ, Littke T, et al
Patients of childbearing potential should also receive counseling on contraception and planned pregnancy, since the review notes limited pregnancy data and recommends stopping GLP-1RAs at least two months before planned conception